EO2(TM) Concepts Awarded Contract with Premier Healthcare Alliance for TransCu O2® Device
SAN ANTONIO, July 11, 2012 /PRNewswire-iReach/ — Electrochemical Oxygen Concepts (EO2(TM) Concepts) announced today that it has been awarded a group purchasing agreement with the Premier Healthcare Alliance for its new wound care therapy device. The new agreement allows Premier members to take advantage of special pricing and terms pre-negotiated by Premier for the TransCu O2(®) device.
“We are proud to be represented by the Premier Healthcare Alliance and look forward to providing its members with our revolutionary wound care therapy,” said EO2(TM) Concepts CEO Michael Wells. “EO2(TM) Concepts is committed to transforming the lives of those who suffer from difficult-to-heal wounds with treatment that is highly effective and supports a normal quality of life.”
The TransCu O2(® )is a simple-to-use and easy-to-administer therapy that provides a continuous supply of low-flow pure oxygen to treat a variety of lower limb wound types such as venous leg ulcers, diabetic foot ulcers, and pressure ulcers. Oxygen-based therapies have been proven effective in treating chronic wounds, yet current therapeutic approaches do not allow for 24-hour a day wound treatment. The TransCu O2(® )device is lightweight and fully portable. Its advanced technology allows for the constant monitoring with automatic flow adjustments necessary for the delivery of optimum therapeutic oxygen flow to the wound site.
About the Premier Healthcare Alliance
Premier is a performance improvement alliance of more than 2,600 U.S. hospitals and 84,000-plus other healthcare sites using the power of collaboration to lead the transformation to high quality, cost-effective care. Owned by hospitals, health systems and other providers, Premier maintains the nation’s most comprehensive repository of clinical, financial and outcomes information and operates a leading healthcare purchasing network. A world leader in helping deliver measurable improvements in care, Premier has worked with the Centers for Medicare & Medicaid Services and the United Kingdom’s National Health Service North West to improve hospital performance. Headquartered in Charlotte, N.C., Premier also has an office in Washington. http://www.premierinc.com. Stay connected with Premier on Facebook, Twitter and YouTube.
About Electrochemical Oxygen Concepts (EO2(TM) Concepts):
EO2(TM) Concepts is a privately held advanced wound care technology company and the developer of an innovative FDA cleared Class III medical device that provides therapy to difficult-to-heal wounds. The TransCu O2(®) is an electrochemical low-dose tissue oxygenation and wound monitoring system designed for use with advanced wound dressings as an adjunctive therapy to treat oxygen compromised wounds. For more information, please visit www.eo2concepts.com.
Media Contact: Ted Buchter EO2 Concepts, (865) 323-1312, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE Electrochemical Oxygen Concepts